BioCentury | Apr 25, 2016
Finance

Saved by a SNP

At a time when venture dollars for cardiovascular companies are dwindling, DalCor Pharma U.K. Ltd. found a syndicate willing to go against the grain. Heart disease is still a leading cause of mortality, but many...
BioCentury | Apr 20, 2016
Financial News

DalCor raises $100M in series B

...U.K. Ltd. (London, U.K.) raised $100 million in a series B round with Sanderling Ventures, Andre Desmarais...
Items per page:
1 - 2 of 2
BioCentury | Apr 25, 2016
Finance

Saved by a SNP

At a time when venture dollars for cardiovascular companies are dwindling, DalCor Pharma U.K. Ltd. found a syndicate willing to go against the grain. Heart disease is still a leading cause of mortality, but many...
BioCentury | Apr 20, 2016
Financial News

DalCor raises $100M in series B

...U.K. Ltd. (London, U.K.) raised $100 million in a series B round with Sanderling Ventures, Andre Desmarais...
Items per page:
1 - 2 of 2